Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - GENVEC INCv338942_ex99-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 22, 2013

 

GENVEC, INC.

(Exact name of registrant as specified in its charter)

 

     
Delaware 0-24469 23-2705690
(State or other jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)

 

 

 

 

65 West Watkins Mill Road, Gaithersburg, Maryland 20878
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (240) 632 0740

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

INFORMATION TO BE INCLUDED IN THE REPORT

 

 

Section 2 – Financial Information

 

Item 2.02 Results of Operations and Financial Condition.

 

On March 22, 2013, GenVec, Inc. (“GenVec”) issued a press release announcing its financial results for the quarter and year ended December 31, 2012.

 

A copy of GenVec’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits
   
99.1 GenVec, Inc. press release dated March 22, 2013, announcing financial results for the quarter and year ended December 31, 2012.

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  GENVEC, INC.
   
Date: March 22, 2013 By:  /s/ Douglas J. Swirsky
    Douglas J. Swirsky
Senior Vice President, Chief Financial Officer, Treasurer and Corporate Secretary

 

3
 

 

EXHIBIT INDEX

 

99.1GenVec, Inc. press release dated March 22, 2013, announcing financial results for the quarter and year ended December 31, 2012.

 

4